Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults (Q35878625)

10 August 2017

1 reference

title

Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults (English)

1 reference

10 August 2017

1 reference

Jirí Beran

1

1 reference

10 August 2017

Lenka Hobzova

2

1 reference

10 August 2017

Veronika Wertzova

3

1 reference

10 August 2017

Sherine Kuriyakose

4

1 reference

10 August 2017

Maarten Leyssen

5

1 reference

10 August 2017

Murielle Surquin

6

1 reference

10 August 2017

Sophie Houard

7

1 reference

10 August 2017

1 July 2010

1 reference

10 August 2017

1 reference

10 August 2017

6

1 reference

10 August 2017

7

1 reference

10 August 2017

578-584

1 reference

The global impact of vaccination against hepatitis B: a historical overview

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

New hepatitis B vaccine formulated with an improved adjuvant system

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

11 July 2018

RTS,S/AS02A for malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Targeting the innate immune response with improved vaccine adjuvants

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Vaccination against hepatitis B infection in patients with end stage renal disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Persistence of specific antibodies after hepatitis B vaccination

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Factors influencing response to hepatitis B virus vaccination in hemodialysis patients

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322521

Are booster immunisations needed for lifelong hepatitis B immunity?

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.6.7.11883

A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.6.7.11883

Persistence of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis B vaccine: role of a booster dose on antibody response

21 January 2018

1 reference

12 December 2020

Hepatitis B vaccination: how long does protection last?

1 reference

12 December 2020

Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients

1 reference

12 December 2020

Persistence of Hepatitis B Vaccine Immunity in Hemodialysis Patients

1 reference

12 December 2020

Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients

1 reference

12 December 2020

Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine

1 reference

12 December 2020

Progress in the control of viral hepatitis: memorandum from a WHO meeting

1 reference

12 December 2020

Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)

1 reference

12 December 2020

Hepatitis B virus infection in dialysis patients

1 reference

12 December 2020

Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity

1 reference

12 December 2020

Identifiers

DOI

10.4161/HV.6.7.11883

1 reference

release_bgl722alxbdfhmwsr3g7b3dqly

10 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bgl722alxbdfhmwsr3g7b3dqly

24 November 2022

mapped directly with Wikidata item

1 reference

10 August 2017

1 reference